Literature DB >> 35721613

Systemic Profile of Cytokines in Arteriovenous Fistula Patients and Their Associations with Maturation Failure.

Laisel Martinez1, Mikael Perla1, Marwan Tabbara1, Juan C Duque2, Miguel G Rojas1, Nieves Santos Falcon1, Simone Pereira-Simon1, Loay H Salman3, Roberto I Vazquez-Padron1,4.   

Abstract

Background: Systemic cytokines are elevated in patients with chronic kidney disease (CKD) and on hemodialysis compared with the general population. However, whether cytokine levels interfere with vascular remodeling, increasing the risk of arteriovenous fistula (AVF) failure, remains unknown.
Methods: This is a case-control study of 64 patients who underwent surgery for AVF creation (32 with AVF maturation failure and 32 matching controls with successful maturation). A total of 74 cytokines, including chemokines, interferons, interleukins, and growth factors, were measured in preoperative plasma samples using multiplex assays. Sixty-two patients were included in the statistical analyses. Associations with AVF failure were assessed using paired comparisons and conditional logistic regressions accounting for paired strata.
Results: Seven cytokines were significantly higher in patients with AVF maturation failure than in matching controls (G-CSF, IL-6, MDC, RANTES, SDF-1α/β, TGFα, and TPO). Of these, G-CSF (odds ratio [OR]=1.71; 95% confidence interval [95% CI], 1.05 to 2.79 per 10 pg/ml), MDC (OR=1.60, 95% CI, 1.08 to 2.38 per 100 pg/ml), RANTES (OR=1.55, 95% CI, 1.10 to 2.17 per 100 pg/ml), SDF-1α/β (OR=1.18, 95% CI, 1.04 to 1.33 per 1000 pg/ml), and TGFα (OR=1.39, 95% CI 1.003, 1.92 per 1 pg/ml) showed an incremental association by logistic regression. Conclusions: This study identified a profile of plasma cytokines associated with adverse maturation outcomes in AVFs. These findings may open the doors for future therapeutics and markers for risk stratification.
Copyright © 2022 by the American Society of Nephrology.

Entities:  

Keywords:  arteriovenous fistula; chronic kidney disease; cytokine; dialysis; inflammation

Mesh:

Substances:

Year:  2022        PMID: 35721613      PMCID: PMC9136910          DOI: 10.34067/KID.0006022021

Source DB:  PubMed          Journal:  Kidney360        ISSN: 2641-7650


  90 in total

1.  Circulating endotoxemia: a novel factor in systemic inflammation and cardiovascular disease in chronic kidney disease.

Authors:  Christopher W McIntyre; Laura E A Harrison; M Tarek Eldehni; Helen J Jefferies; Cheuk-Chun Szeto; Stephen G John; Mhairi K Sigrist; James O Burton; Daljit Hothi; Shvan Korsheed; Paul J Owen; Ka-Bik Lai; Philip K T Li
Journal:  Clin J Am Soc Nephrol       Date:  2010-09-28       Impact factor: 8.237

2.  Thrombopoietin stimulates endothelial cell motility and neoangiogenesis by a platelet-activating factor-dependent mechanism.

Authors:  M F Brizzi; E Battaglia; G Montrucchio; P Dentelli; L Del Sorbo; G Garbarino; L Pegoraro; G Camussi
Journal:  Circ Res       Date:  1999-04-16       Impact factor: 17.367

3.  Transcriptomics of Human Arteriovenous Fistula Failure: Genes Associated With Nonmaturation.

Authors:  Laisel Martinez; Marwan Tabbara; Juan C Duque; Guillermo Selman; Nieves Santos Falcon; Angela Paez; Anthony J Griswold; Gioser Ramos-Echazabal; Diana R Hernandez; Omaida C Velazquez; Loay H Salman; Roberto I Vazquez-Padron
Journal:  Am J Kidney Dis       Date:  2019-02-27       Impact factor: 8.860

Review 4.  Recent advances on the role of cytokines in atherosclerosis.

Authors:  Hafid Ait-Oufella; Soraya Taleb; Ziad Mallat; Alain Tedgui
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-05       Impact factor: 8.311

5.  Association of serum lipid profile and arteriovenous fistula thrombosis in maintenance hemodialysis patients.

Authors:  Alper Kirkpantur; Mustafa Arici; Bulent Altun; Mahmut Ilker Yilmaz; Barbaros Cil; Tuncay Aki; Mehmet Bakkaloglu; Cetin Turgan
Journal:  Blood Purif       Date:  2008-05-19       Impact factor: 2.614

6.  Transforming growth factor alpha induces angiogenesis and neurogenesis following stroke.

Authors:  R R Leker; Z E Toth; T Shahar; R Cassiani-Ingoni; I Szalayova; S Key; A Bratincsák; E Mezey
Journal:  Neuroscience       Date:  2009-05-27       Impact factor: 3.590

Review 7.  Smooth muscle cell fate and plasticity in atherosclerosis.

Authors:  Sima Allahverdian; Chiraz Chaabane; Kamel Boukais; Gordon A Francis; Marie-Luce Bochaton-Piallat
Journal:  Cardiovasc Res       Date:  2018-03-15       Impact factor: 10.787

8.  Regulation of endothelial cell adhesion molecule expression by mast cells, macrophages, and neutrophils.

Authors:  Jie Zhang; Pilar Alcaide; Li Liu; Jiusong Sun; Aina He; Francis W Luscinskas; Guo-Ping Shi
Journal:  PLoS One       Date:  2011-01-14       Impact factor: 3.240

9.  Senescent Vascular Smooth Muscle Cells Drive Inflammation Through an Interleukin-1α-Dependent Senescence-Associated Secretory Phenotype.

Authors:  Sarah E Gardner; Melanie Humphry; Martin R Bennett; Murray C H Clarke
Journal:  Arterioscler Thromb Vasc Biol       Date:  2015-07-02       Impact factor: 8.311

10.  Chemokine Ligand 5 (CCL5) Derived from Endothelial Colony-Forming Cells (ECFCs) Mediates Recruitment of Smooth Muscle Progenitor Cells (SPCs) toward Critical Vascular Locations in Moyamoya Disease.

Authors:  Ji Hoon Phi; Naoko Suzuki; Youn Joo Moon; Ae Kyung Park; Kyu-Chang Wang; Ji Yeoun Lee; Seung-Ah Choi; Sangjoon Chong; Reizo Shirane; Seung-Ki Kim
Journal:  PLoS One       Date:  2017-01-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.